Jeanne Allinne

Jeanne Allinne possesses extensive expertise in immuno-inflammation and antibody research, with significant roles at Servier as Program Director and Project Leader from September 2019 to December 2020, where responsibilities included establishing an immuno-inflammation research group and identifying targets for autoimmune disease treatments. At Regeneron Pharmaceuticals, Inc., from January 2014 to August 2019, Jeanne held positions from Staff Scientist to Senior Staff Scientist, focusing on the development of therapeutic monoclonal antibodies and leading research teams to validate new targets. Previous experience includes a Postdoctoral Fellowship at NYU Langone Medical Center concentrating on gene regulation during immune cell development and a PhD in Oncology from Institut Gustave Roussy. Additionally, teaching assistance in cellular and molecular biology was provided at Université Paris-Sud.